PHOSPHATURIC MESENCHYMAL TUMOUR

This adverse event was reported 11 times

These drugs are most commonly taken by patients reporting PHOSPHATURIC MESENCHYMAL TUMOUR:

# Drug Count
0 CINACALCET 4
1 CINACALCET HYDROCHLORIDE 4
2 DENOSUMAB 4
3 IRON 2
4 TERIPARATIDE 2
5 CALCITRIOL 1
6 CALCITRIOL CAPSULES 0.25 MCG 1
7 CALCITRIOL CAPSULES 0.5 MCG 1
8 INSULIN 1
9 METFORMIN 1
See all common drugs associated with PHOSPHATURIC MESENCHYMAL TUMOUR

PHOSPHATURIC MESENCHYMAL TUMOUR is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CINACALCET HYDROCHLORIDE 4 0.0001
1 CALCITRIOL CAPSULES 0.25 MCG 1 0.0000
2 IRON 2 0.0000
3 PIOGLITAZONE 1 0.0000
4 DENOSUMAB 4 0.0000
5 TERIPARATIDE 2 0.0000
6 METFORMIN ER 500 MG 1 0.0000
See all drugs enriched for association with PHOSPHATURIC MESENCHYMAL TUMOUR

PHOSPHATURIC MESENCHYMAL TUMOUR is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Vitamin D3 Analog [EPC] 1 0.0000
1 RANK Ligand Inhibitor [EPC] 4 0.0000
2 Parathyroid Hormone Analog [EPC] 2 0.0000
3 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
4 Insulin Analog [EPC] 1 0.0000
See all drug classes enriched for association with PHOSPHATURIC MESENCHYMAL TUMOUR